Skip to main content
Universe Pharmaceuticals INC logo

Universe Pharmaceuticals INC — Investor Relations & Filings

Ticker · UPC ISIN · KYG9442G1047 US Manufacturing
Open in API
Filings indexed 99 across all filing types
Latest filing 2022-08-16 Interim / Quarterly Rep…
Country US United States of America
Listing US UPC

About Universe Pharmaceuticals INC

http://www.universe-pharmacy.com/

Universe Pharmaceuticals INC is a pharmaceutical company specializing in the manufacturing, marketing, sales, and distribution of traditional Chinese medicine (TCM) derivative products. Through its subsidiaries, the company's product portfolio also includes biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed by a foreign private issuer, Universe Pharmaceuticals INC, reporting financial results for the six months ended August 16, 2022. It includes unaudited condensed interim consolidated financial statements and Management's Discussion and Analysis (MD&A). Form 6-K is used by foreign private issuers to report interim financial information and other material events. The presence of interim financial statements and MD&A indicates this is an Interim / Quarterly Report. The document is over 5,000 characters and contains substantive financial data, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR).
2022-08-16 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a press release about receiving a Nasdaq notification regarding minimum bid price deficiency. The document is short (1766 characters) and primarily serves as a regulatory announcement rather than a full financial report or detailed filing. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents.
2022-07-19 English
SCHEDULE 13G
Major Shareholding Notification
2022-02-11 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a press release reporting fiscal year 2021 financial results but does not contain the full annual report or detailed financial statements itself. The document length is short (1713 characters), and it primarily serves as a regulatory filing to announce the press release. According to the rules, such filings are classified as Regulatory Filings (RNS) because they do not contain the full report but rather an announcement or submission of information.
2022-01-31 English
ANNUAL REPORT
Annual Report FY 2021
2022-01-31 English
UPC PURA VIDA 13G
Major Shareholding Notification
2021-12-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.